Skip to main content
Delayed
Smart Investors Daily
PM

NASDAQ · PMI

Picard Medical, Inc.

Healthcare · Medical - Devices

$4.61

Down-$0.11 (-2.39%)

Updated Sep 29, 2026, 4:49 PM

SID Score

3.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.85B
P/E ratio
-4.16
Dividend yield
0.00%
52-week range
$2.65 – $684.00
Volume
52.04K
Avg. volume
2.55M

Price performance · PMI

PMI price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Sep 28, 2026

PMI closed at $4.61 after 20 trading sessions, down 45.51% for the selected period.

Last close
$4.61
Period change
-45.51%
Period low
$3.86
Period high
$8.46
Daily close
View OHLC price history
PMI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 28, 2026$4.49$4.7498$4.0301$4.6152.04K
Sep 25, 2026$4.72$4.80$4.56$4.6234.37K
Sep 24, 2026$4.50$4.87$4.28$4.8756.98K
Sep 23, 2026$4.25$4.58$4.25$4.5592.47K
Sep 22, 2026$3.89$4.33$3.83$4.33216.27K
Sep 21, 2026$4.36$4.639$4.20$4.21173.62K
Sep 18, 2026$5.62$5.705$4.91$5.08213.49K
Sep 17, 2026$6.40$7.10$5.50$5.60218.47K
Sep 16, 2026$6.18$6.81$6.12$6.48146.35K
Sep 15, 2026$6.07$6.8699$6.0002$6.39285.33K
Sep 14, 2026$5.51$6.40$5.51$6.26588.93K
Sep 11, 2026$4.56$5.33$4.55$5.33523.24K
Sep 10, 2026$4.30$5.00$4.18$4.41321.91K
Sep 9, 2026$4.25$4.65$4.0459$4.41250.24K
Sep 8, 2026$4.70$4.77$4.24$4.31197.48K
Sep 4, 2026$4.46$5.3521$4.3447$4.56513.18K
Sep 3, 2026$4.54$4.60$4.1005$4.49306.95K
Sep 2, 2026$3.87$4.78$3.5015$4.58828.67K
Sep 1, 2026$8.24$8.97$3.80$3.861.6M
Aug 31, 2026$8.04$11.87$7.92$8.462.25M

Latest PMI news

The latest Smart Investors Daily articles mentioning PMI.

PMI research

Overview

Company profile and research snapshot.

Company profile

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
PMI recent ratings
DateFirmRatingTarget
Jun 3, 2026HC Wainwright & Co.Neutral—
May 18, 2026HC Wainwright & Co.Neutral—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Sep 14, 2026

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company's

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.